[1]
“Development and Optimization of Acyl Chitosan-based SNEDDS for enhanced Oral Bioavailability of Lipophilic Drugs”, IJPDD, vol. 3, no. 1, pp. 22–27, Jan. 2026, doi: 10.62896/ijpdd.3.1.05.